ReviewPediatric nephrology (Berlin, Germany)2020
Management of antenatal hydronephrosis.
Review in Pediatric nephrology (Berlin, Germany), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- Prediction of split renal function and obstruction with magnetic resonance urography in comparison with dynamic renal scintigraphy.Pediatric nephrology (Berlin, Germany) · 2026Article
- Clinical significance and management of antenatally detected hydronephrosis due to ureteropelvic junction obstruction: a retrospective single-center study.BMC pediatrics · 2026Article
- Is BMP-7 a promising diagnostic and prognostic biomarker for pediatric obstructive uropathy?BMC urology · 2026Observational
- Genetic diagnosis in fetal hydronephrosis: assessment using chromosomal microarray analysis and whole-genome sequencing.Human genomics · 2026Article
- Congenital urinary tract dilation: when is it clinically significant and when should it prompt intervention?Frontiers in pediatrics · 2026Article
- Laparoscopic pyeloplasty in infants with ureteropelvic junction obstruction managed with the enhanced recovery after surgery approach: a single-center experience.BMC urology · 2025Article
- Optimizing postnatal management based on prenatal UTD grading: a 5-year follow-up study of fetal hydronephrosis in a large Chinese cohort.BMC pediatrics · 2025Article
- Novel multifunctional targeted nanozyme as an ultrasound contrast agent for real-time monitoring and treatment of congenital hydronephrosis renal fibrosis.Journal of nanobiotechnology · 2025Article
- Comparison of the treatment effect of laparoscopic and robot-assisted single-port laparoscopic pyeloplasty on ureteropelvic junction obstruction in infants.Journal of robotic surgery · 2025Article
- Development of LncRNA Biomarkers in Extracellular Vesicle of Amniotic Fluid Associated with Antenatal Hydronephrosis.Biomedicines · 2025Article
- Feasibility analysis of ambulatory surgery in pediatric ureteropelvic junction obstruction.Frontiers in pediatrics · 2025Article
- Evaluation of postoperative renal function in infants with congenital hydronephrosis using ROI from ultrasound technique in renography.BMC pediatrics · 2024Article
- Predicting clinically significant events in children with ureteropelvic junction obstruction.Frontiers in pediatrics · 2024Article
- Obstacles and sustainability of enhanced recovery after surgery in pediatric laparoscopic pyeloplasty.Frontiers in pediatrics · 2024Article
- Associations between PMFrontiers in public health · 2024Article
- Article
- The correlation between GFR and unit renal volume in infants with hydronephrosis measured by two imaging methods.Scientific reports · 2023Article
- Multiomics-based study of amniotic fluid small extracellular vesicles identified Moesin as a biomarker for antenatal hydronephrosis.Clinical and translational medicine · 2023Article
- Clinical characteristics of patients with prenatal hydronephrosis in early postnatal period: a single center retrospective study.BMC pediatrics · 2023Article
- Exacerbation of Congenital Hydronephrosis as the First Presentation of COVID-19 Infection in Children.Case reports in nephrology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antenatal hydronephrosis (AHN) is the most frequently detected abnormality by prenatal ultrasonography. Differential diagnosis of AHN includes a wide variety of congenital abnormalities of the kidney and urinary tract ranging from mild abnormalities such as transient or isolated AHN to more important ones as high-grade congenital vesicoureteral reflux or ureteropelvic junction obstruction. It is well known that the outcome depends on the underlying etiology. Various grading systems have been proposed for the classification of AHN on prenatal and postnatal ultrasonography. Mild isolated AHN represents up to 80% of cases, is considered to be benign, and majority of them resolve, stabilize, or improve during follow-up. Controversies exist regarding the diagnosis and management of some important and severe causes of AHN such as high-grade vesicoureteral reflux and ureteropelvic junction obstruction. Current approach is becoming increasingly conservative during diagnosis and follow-up of these patients with less imaging and close follow-up. However, there is still no consensus regarding the clinical significance, postnatal evaluation, and management of infants with AHN. The aim of this review is to discuss the controversies and provide an overview on the management of AHN.
Indexed as
Identifiers
31811536What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.